CECL for Non-Financial Institutions

CECL for Non-Financial Institutions: Navigating New Accounting Waters

The introduction of the Current Expected Credit Loss (CECL) model by the Financial Accounting Standards Board (FASB) in 2016 marks a significant evolution in accounting standards, with vast implications for how credit losses on financial assets are estimated. Implemented in…
Guidance on the Treatment of Research and Experimental Expenditures

IRS Releases Substantive Guidance on the Treatment of Research and Experimental Expenditures Under Section 174

On September 8, 2023, the IRS released pre-regulatory guidance concerning the requirement to capitalize and amortize specified research and experimental (SRE) expenditures under Internal Revenue Code Section 174, as revised by the 2017 Tax Cuts and Jobs Act (TCJA). Notice…
Massachusetts Corporate and Individual Tax

Massachusetts Enacts Corporate and Individual Tax Changes

On October 4, 2023, Massachusetts Gov. Maura Healy signed H. 4104 to enact numerous business and individual tax changes. The more significant changes include adopting single-sales-factor apportionment for all corporate taxpayers, changing the sourcing of financial institution receipts from investment and trading,…
Research and Experimental

Easing The Pain of Research & Experimental (R&E) Expenditure Capitalization

The new Section 174 rules require taxpayers to capitalize and amortize R&E costs incurred in taxable years beginning on or after Jan. 1, 2022. Amortization is calculated using a straight‐line recovery period of either five years for costs incurred in…
Research and development changes

What businesses need to know about the recent Research and Development changes

Written by: Leah Belanger, CPA, MSA The world of tax law is constantly shifting, creating challenges and opportunities for businesses. One recent change that has generated considerable confusion and debate involves alterations to tax incentives for Research and Development (R&D)…